|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| PubMed |
32405160 |
Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia.
Background: Pneumonia with respiratory failure represents the main cause of death in COVID-19, where hyper |
1.84 KB |
2020-05-21 |
|
3 |
|
6 |
2021-01-18
|
| PubMed |
32403946 |
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).
Background: We describe cancer patients with coronavirus disease-2019 (COVID-19) inf |
1.11 KB |
2020-05-21 |
|
2 |
|
5 |
2021-01-18
|
| PubMed |
32400362 |
Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020.
Data on features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in |
667 Bytes |
2020-05-21 |
|
3 |
|
2 |
2021-01-18
|
| PubMed |
32400349 |
Identification of Falsified Chloroquine Tablets in Africa at the Time of the COVID-19 Pandemic.
Reports that chloroquine and hydroxychloroquine may be effective against COVID-19 have received worldwid |
1.23 KB |
2020-05-21 |
|
3 |
|
0 |
2021-01-18
|
| PubMed |
32400323 |
In vitro data of current therapies for SARS-CoV-2.
BACKGROUND: In December 2019, a new coronavirus, named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has emerged from China causing p |
1.16 KB |
2020-05-21 |
|
22 |
|
1 |
2021-01-18
|
| PubMed |
32397911 |
COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics.
At the time of writing this review, severe acute respiratory coronavirus syndrome-2 ( |
1.08 KB |
2020-05-21 |
|
2 |
|
0 |
2021-01-18
|
| PubMed |
32397174 |
Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity.
On 7 January 2020, researchers isolated and sequenced in Chi |
1.62 KB |
2020-05-21 |
|
3 |
|
9 |
2021-01-18
|
| PubMed |
32366611 |
Severe Pediatric COVID-19 Presenting With Respiratory Failure and Severe Thrombocytopenia.
|
91 Bytes |
2020-05-21 |
|
23 |
|
2 |
2021-01-18
|
| PubMed |
32367579 |
The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.
Drug repurposing is potentially the fastest available option in the ra |
1.56 KB |
2020-05-21 |
|
3 |
|
0 |
2021-01-18
|
| PubMed |
32372695 |
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.
More than 2,000,000 individuals worldwide have had coronavirus 2019 disease infection (COVID-19), yet ther |
1.77 KB |
2020-05-21 |
|
2 |
|
5 |
2021-01-18
|
